The American Academy of Pediatrics (AAP) wants to make pediatric study exemptions and delays harder to come by in legislation reauthorizing the US FDA’s drug user fee programs.
The professional organization is working on changes aimed at getting voluntary pediatric studies conducted under the Best Pharmaceuticals for Children...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?